Erythrocyte membrane, plasma and atherosclerotic plaque lipid pattern in coronary heart disease

Medicina

Volumn 67, Issue 5, 2007, Pages 451-457

  Lausada, Natalia Raquel ^a   Boullon, Sebastian ^b   Boullon, Fernando ^b   Tacconi De Gomez Dumm, Irma N ^a  

^a INSTITUTO DE INVESTIGACIONES BIOQUÍMICAS DE LA PLATA INIBIOLP   (Argentina)

^b Unidad Asistencial Dr César Milstein   (Argentina)

Author keywords

Coronary arteriosclerosis; Dyslipidemia; Endarterectomy; Erythrocyte membranes; Fatty acids

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FATTY ACID; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ISOSORBIDE MONONITRATE; LIPID; ORAL ANTIDIABETIC AGENT; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL MEMBRANE FLUIDITY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; ENDARTERECTOMY; ERYTHROCYTE LEVEL; ERYTHROCYTE MEMBRANE; ESSENTIAL FATTY ACID DEFICIENCY; FATTY ACID ANALYSIS; FATTY ACID BLOOD LEVEL; FEMALE; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; HUMAN; HUMAN CELL; ISCHEMIC HEART DISEASE; LIPID COMPOSITION; MALE; PHOSPHOLIPID BLOOD LEVEL; REFERENCE VALUE; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; CHOLESTEROL; CORONARY ARTERY DISEASE; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; ERYTHROCYTE MEMBRANE; FATTY ACIDS; FATTY ACIDS, ESSENTIAL; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; PHOSPHOLIPIDS; TRIGLYCERIDES;

EID: 36049045665     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Levin R, Tolstanol A, Andreu E, Tajes H, Tanus E, Boullon F, et al. Endarterectomía coronaria. Parte 1 (resultados iniciales). Rev Argent Cardiol 1999; 67: 747-52.
2. Peng S, Guo W, Morrisett JD, Johnstone MT, Hamilton JA. Quantification of cholesteryl esters in human and rabbit atherosclerotic plaques by magic-angle spinning (13) C-NMR. Arterioscler Thromb Vasc Biol 2000; 20: 2682-8.
3. Weissberg P. Mechanisms modifying atherosclerotic disease - from lipids to vascular biology. Atherosclerosis 1999;147 Suppl 1: S3-10.
4. de Korte CL, Pasterkamp G, van der Steen AF, Woutman HA, Bom N. Characterization of plaque components with intravascular ultrasound elastography in human femoral and coronary arteries in vitro. Circulation 2000; 102: 617-23.
5. Marinello E, Setacci C, Giubbolini M, et al. Lipid composition in atheromatous plaque: evaluation of the lipid three-phase percentage. Life Sci 2003; 72: 2689-94.
6. McGrath LT, Elliott RJ. Lipid analysis and fatty acid profiles of individual arterial atherosclerotic plaques. Anal Biochem 1990; 187: 273-6.
7. Romer TJ, Brennan JF, Schut TC, et al. Raman spectroscopy for quantifying cholesterol in intact coronary artery wall. Atherosclerosis 1998; 141: 117-24.
8. Harris WS, Sands SA, Windsor SL, et al. Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation. Circulation 2004; 110: 1645-9.
9. Harris WS Von Schacky C. The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med 2004; 39: 212-20.
10. Sands SA RK, Windsor SL, Harris WS. The Impact of age, body mass index, and fish intake on the EPA and DHA content of human erythrocytes. Lipids 2005; 40: 343-7.
11. Walker BL, Yurkowski M. Effect of cell age on erythrocyte fatty acid composition in rats on different dietary regimes. Biochem J 1967; 103: 218-24.
12. Cazzola R, Rondanelli M, Russo-Volpe S, Ferrari E, Cestaro B. Decreased membrane fluidity and altered susceptibility to peroxidation and lipid composition in overweight and obese female erythrocytes. J Lipid Res 2004; 45: 1846-51.
13. Felton CV, Stevenson JC, Godsland IF. Erythrocyte-derived measures of membrane lipid composition in healthy men: associations with arachidonic acid at low to moderate but not high insulin sensitivity. Metabolism 2004; 53: 571-7.
14. Parmahamsa M, Reddy KR, Varadacharyulu N. Changes in composition and properties of erythrocyte membrane in chronic alcoholics. Alcohol Alcohol 2004; 39:110-2.
15. Kulacoglu DN, Kocer I, Kurtul N, Keles S, Baykal O. Alterations of fatty acid composition of erythrocyte membrane in type 2 diabetes patients with diabetic retinopathy. Jpn J Ophthalmol 2003; 47: 551-6.
16. Thies F, Garry JM, Yaqoob P, et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet 2003; 361: 477-85.
17. De Caterina R, Spiecker M, Solaini G, et al. The inhibition of endothelial activation by unsaturated fatty acids. Lipids. 1999; 34 Suppl: S191-4.
18. von Schacky C. The role of omega-3 fatty acids in cardiovascular disease. Curr Atheroscler Rep 2003; 5: 139-45.
19. von Schacky C. Omega-3 fatty acids and cardiovascular disease. Curr Opin Clin Nutr Metab Care 2004; 7: 131-6.
20. Brenner RR, Bernasconi AM, Gonzalez MS, Rimoldi OJ. Dietary cholesterol modulates delta6 and delta9 desaturase mRNAs and enzymatic activity in rats fed a low-eFA diet. Lipids 2002; 37: 375-83.
21. Kaysen GA. Hyperlipidemia of chronic renal failure. Blood Purif 1994; 12: 60-7.
22. Guyton JR, Klemp KF. Development of the lipid-rich core in human atherosclerosis. Arterioscler Thromb Vasc Biol 1996; 16: 4-11.
23. Katz SS, Small DM. Isolation and and partial characterization of the lipid phases of human atherosclerotic plaques. J Biol Chem 1980; 255: 9753-9.
24. Lee RT, Libby P. The unstable atheroma. Arterioscler Thromb Vasc Biol 1997; 17: 1859-67.
25. Tabas I. Cholesterol and phospholipid metabolism in macrophages. Biochim Biophys Acta 2000; 1529: 164-74.
26. Burke AP, Kolodgie FD, Zieske A, et al. Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study. Arterioscler Thromb Vasc Biol 2004; 24: 1266-71.
27. Macphee CH. Lipoprotein-associated phospholipase A2: a potential new risk factor for coronary artery disease and a therapeutic target. Curr Opin Pharmacol 2001; 1: 121-5.